News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
667,582 Results
Type
Article (58853)
Company Profile (142)
Press Release (608587)
Multimedia
Podcasts (69)
Webinars (14)
Section
Business (181087)
Career Advice (2880)
Deals (33554)
Drug Delivery (120)
Drug Development (77610)
Employer Resources (188)
FDA (15232)
Job Trends (14758)
News (315659)
Policy (30679)
Tag
Academia (2794)
Academic (2)
Accelerated approval (6)
Adcomms (25)
Allergies (90)
Alliances (45708)
ALS (93)
Alzheimer's disease (1345)
Antibody-drug conjugate (ADC) (126)
Approvals (15237)
Artificial intelligence (281)
Autoimmune disease (24)
Automation (16)
Bankruptcy (310)
Best Places to Work (11512)
BIOSECURE Act (20)
Biosimilars (109)
Biotechnology (91)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (274)
Cancer (2233)
Cardiovascular disease (168)
Career advice (2437)
Career pathing (34)
CAR-T (162)
Cell therapy (443)
Cervical cancer (21)
Clinical research (63043)
Collaboration (833)
Company closure (1)
Compensation (366)
Complete response letters (24)
COVID-19 (2612)
CRISPR (44)
C-suite (261)
Cystic fibrosis (103)
Data (2169)
Decentralized trials (2)
Denatured (29)
Depression (48)
Diabetes (260)
Diagnostics (6399)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (123)
Drug pricing (108)
Drug shortages (24)
Duchenne muscular dystrophy (89)
Earnings (63669)
Editorial (41)
Employer branding (25)
Employer resources (161)
Events (101115)
Executive appointments (765)
FDA (16510)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (762)
Gene editing (110)
Generative AI (24)
Gene therapy (306)
GLP-1 (711)
Government (4727)
Grass and pollen (6)
Guidances (64)
Healthcare (18899)
Huntington's disease (21)
IgA nephropathy (26)
Immunology and inflammation (120)
Indications (29)
Infectious disease (2753)
Inflammatory bowel disease (141)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (97)
Interviews (543)
IPO (15301)
IRA (40)
Job creations (3643)
Job search strategy (2048)
Kidney cancer (10)
Labor market (36)
Layoffs (518)
Leadership (23)
Legal (6898)
Liver cancer (74)
Lung cancer (321)
Lymphoma (146)
Machine learning (7)
Management (63)
Manufacturing (300)
MASH (65)
Medical device (12750)
Medtech (12755)
Mergers & acquisitions (18832)
Metabolic disorders (666)
Multiple sclerosis (80)
NASH (19)
Neurodegenerative disease (86)
Neuropsychiatric disorders (27)
Neuroscience (1887)
NextGen: Class of 2025 (6739)
Non-profit (4740)
Now hiring (39)
Obesity (347)
Opinion (242)
Ovarian cancer (74)
Pain (92)
Pancreatic cancer (78)
Parkinson's disease (146)
Partnered (21)
Patents (238)
Patient recruitment (113)
Peanut (49)
People (60202)
Pharmaceutical (38)
Pharmacy benefit managers (15)
Phase I (19795)
Phase II (27791)
Phase III (20496)
Pipeline (1171)
Policy (135)
Postmarket research (2467)
Preclinical (8429)
Press Release (69)
Prostate cancer (109)
Psychedelics (33)
Radiopharmaceuticals (252)
Rare diseases (372)
Real estate (6196)
Recruiting (75)
Regulatory (21159)
Reports (50)
Research institute (2468)
Resumes & cover letters (432)
Rett syndrome (5)
RNA editing (4)
RSV (41)
Schizophrenia (71)
Series A (136)
Series B (84)
Service/supplier (12)
Sickle cell disease (54)
Special edition (12)
Spinal muscular atrophy (148)
Sponsored (31)
Startups (3525)
State (1)
Stomach cancer (12)
Supply chain (60)
Tariffs (32)
The Weekly (38)
Vaccines (701)
Venture capitalists (41)
Weight loss (227)
Women's health (34)
Worklife (20)
Date
Today (37)
Last 7 days (856)
Last 30 days (2494)
Last 365 days (31436)
2025 (10515)
2024 (33583)
2023 (37813)
2022 (48165)
2021 (53130)
2020 (52314)
2019 (46531)
2018 (35466)
2017 (31626)
2016 (31084)
2015 (36449)
2014 (29311)
2013 (25589)
2012 (27195)
2011 (27412)
2010 (26063)
Location
Africa (928)
Alabama (56)
Alaska (7)
Arizona (196)
Arkansas (14)
Asia (39120)
Australia (6840)
California (5720)
Canada (1914)
China (511)
Colorado (256)
Connecticut (266)
Delaware (143)
Europe (89772)
Florida (869)
Georgia (205)
Hawaii (1)
Idaho (57)
Illinois (559)
India (28)
Indiana (300)
Iowa (10)
Japan (155)
Kansas (99)
Kentucky (25)
Louisiana (11)
Maine (60)
Maryland (863)
Massachusetts (4205)
Michigan (238)
Minnesota (354)
Mississippi (2)
Missouri (88)
Montana (29)
Nebraska (24)
Nevada (62)
New Hampshire (60)
New Jersey (1684)
New Mexico (30)
New York (1687)
North Carolina (984)
North Dakota (9)
Northern California (2491)
Ohio (199)
Oklahoma (15)
Oregon (37)
Pennsylvania (1256)
Puerto Rico (11)
Rhode Island (29)
South America (1244)
South Carolina (18)
South Dakota (1)
Southern California (2159)
Tennessee (98)
Texas (855)
United States (21939)
Utah (174)
Virginia (143)
Washington D.C. (60)
Washington State (530)
West Virginia (3)
Wisconsin (62)
667,582 Results for "national academy of sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
A Co-Founder of Athos Therapeutics, Dr. Michael E. Jung, Wins the National Academy of Sciences Award for Chemistry in Service to Society
May 1, 2025
·
3 min read
Press Releases
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
April 9, 2025
·
7 min read
Press Releases
Eascra Biotech Receives U.S. National Science Foundation Grant
April 21, 2025
·
2 min read
Biotech Bay
First-in-Disease Use of Kyverna Therapeutics’ KYV-101 in Patient With Severe Stiff-Person Syndrome Published in Proceedings of the National Academy of Sciences (PNAS)
Kyverna Therapeutics, Inc. (Kyverna) announced today the publication in Proceedings of the National Academy of Sciences (PNAS)1 of a report describing the first use of KYV-101, a fully human anti-CD19 chimeric antigen receptor (CAR) T-cell product candidate, in a 69-year-old patient suffering from treatment-refractory stiff-person syndrome (SPS) as part of a named-patient use in Germany for critically ill individuals who fail conventional therapies.
June 17, 2024
·
6 min read
Business
Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering
Moderna, Inc. announced that Stéphane Bancel, Chief Executive Officer, has been elected to the National Academy of Engineering, broadly known as one of the highest acknowledgments of achievement in the field, in recognition of distinguished contributions to engineering and the “development and manufacturing of pharmaceutical products, including the COVID-19 vaccine.”.
February 7, 2024
·
3 min read
Business
BlossomHill Therapeutics Chief Executive Officer, Jingrong Jean Cui, Ph.D., Elected to the National Academy of Engineering
BlossomHill Therapeutics today announced Jingrong Jean Cui, Ph.D., Co-Founder, President and Chief Executive Officer of BlossomHill Therapeutics, has been elected to the National Academy of Engineering (NAE).
February 14, 2024
·
2 min read
Press Releases
CND Life Sciences to Present Updates from Three Clinical Trials Involving Their Skin Biopsy Diagnostic Tool for Dementia and Other Related Disorders at the American Academy of Neurology 2025 Annual Meeting
March 28, 2025
·
5 min read
Press Releases
Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)
April 21, 2025
·
4 min read
Press Releases
SK Life Science, Inc. to Showcase Important XCOPRI® (cenobamate tablets) CV Data on Responsive Neurostimulation Epileptiform Events at the 77th American Academy of Neurology (AAN) Annual Meeting
April 4, 2025
·
12 min read
Press Releases
Children’s Hospital of Philadelphia Leader in Sickle Cell Disease Elected to National Academy of Medicine
October 22, 2024
·
4 min read
1 of 66,759
Next
